Evidence map›Paper›PMID 36137760›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.

Anne M Smith, Nancy A Obuchowski, Norman L Foster, Gregory Klein, P David Mozley, Adriaan A Lammertsma, Richard L Wahl, John J Sunderland, Jean-Luc Vanderheyden, Tammie L S Benzinger and 5 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  11. Article
  12. Quantitative Brain Amyloid PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anne M SmithSiemens Medical Solutions USA, Inc., Knoxville, Tennessee; anne.m.smith@siemens-healthineers.com.
Nancy A ObuchowskiQuantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Norman L FosterDepartment of Neurology, University of Utah, Salt Lake City, Utah.
Gregory KleinF. Hoffmann-La Roche Ltd., Basel, Switzerland.
P David MozleyWeill Medical College of Cornell University, New York, New York.
Adriaan A LammertsmaAmsterdam Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
Richard L WahlMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
John J SunderlandDivision of Nuclear Medicine, Department of Radiology, University of Iowa, Iowa City, Iowa.
Jean-Luc VanderheydenJLVMI Consulting LLC, Dousman, Wisconsin.
Tammie L S BenzingerMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Paul E KinahanDepartment of Radiology, School of Medicine, University of Washington, Seattle, Washington.
Dean F WongMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Eric S PerlmanPerlman Advisory Group, Hillsdale, New York.
Satoshi MinoshimaDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah; and.
Dawn MatthewsADM Diagnostics, Inc., Northbrook, Illinois.

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI Tammie Lee Smith Benzinger · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7M
DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIAU01AG042791 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2013 to 2018
$8.9M
Partial Volume Correction Methods to Improve Quantitation and Interpretation of Amyloid & Tau PET Imaging in Aging and DementiaR21AG056142 · NIA · JOHNS HOPKINS UNIVERSITY · PI RAHMIM, ARMAN, ROUSSET, OLIVIER · 2017 to 2018
$450k
Comparison of Two Next Generation TAU Radiopharmaceuticals in Alzheimer's DiseaseR21AG062314 · NIA · WASHINGTON UNIVERSITY · PI KUWABARA, HIROTO, WONG, DEAN FOSTER · 2019 to 2020
$438k
NCATS NIH HHS UL1 TR000448NHLBI NIH HHS HHSN268201500021CNIA NIH HHS P01 AG003991NIA NIH HHS P30 AG066444NIA NIH HHS P50 AG005681NIA NIH HHS R21 AG056142NIA NIH HHS R21 AG062314NIA NIH HHS U01 AG042791NIBIB NIH HHS HHSN268201300071C
6 · The paper itself

Abstract

A standardized approach to acquiring amyloid PET images increases their value as disease and drug response biomarkers. Most

Indexed as

Alzheimer DiseaseImage Processing, Computer-AssistedAmyloidAmyloid beta-PeptidesAniline CompoundsBiomarkersBrainHumansPositron-Emission TomographyAmyloidAmyloid beta-PeptidesAniline CompoundsBiomarkersAlzheimer diseaseamyloid PETguidelinesQIBAquantitative imaging biomarkers

Identifiers

PMID36137760
PMCPMC9902844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.